# Aurobindo Pharma Limited - Inspection Records

Source: https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

> Inspection records and compliance data for Aurobindo Pharma Limited in Polepally, Mahaboob Nagar, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurobindo Pharma Limited
- FEI Number: 3007373532
- City: Polepally, Mahaboob Nagar
- State: None
- Country Name: India
- Address Line 1: Unit Vii, Formulation Plant, Green Industrial Park, 411/P, 425/P, 434/P, 435/P & 458/P, Plot No.S1 (Part) Sez (Pharma), Tsiic
- Zip Code: None
- Facility Type: Finished Product Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - Aurobindo Pharma Limited - 2026-02-10](https://www.keypedia.com/records/483/aurobindo-pharma-limited/fa93be5a-0031-4676-b411-4813d0c7f1aa) — source: FDA, date: February 10, 2026
- [FDA Inspection 1304312 - Aurobindo Pharma Limited - 2026-02-10](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/f603cc93-dc47-4606-8cf0-0dde6af906da) — source: FDA, date: February 10, 2026
- [483 - Aurobindo Pharma Limited - 2026-01-28](https://www.keypedia.com/records/483/aurobindo-pharma-limited/4402f9cb-7684-4577-a119-d85aa7d6b1c3) — source: FDA, date: January 28, 2026
- [FDA Inspection 1242351 - Aurobindo Pharma Limited - 2023-08-04](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/c0a3fe70-6c3e-4a61-86d6-a25010bad762) — source: FDA, date: August 4, 2023
- [483 - Aurobindo Pharma Limited - 2022-05-10](https://www.keypedia.com/records/483/aurobindo-pharma-limited/cdc2cd57-b94d-4778-9f26-a81d8d0d6db3) — source: FDA, date: May 10, 2022
- [483 - Aurobindo Pharma Limited - 2022-05-10](https://www.keypedia.com/records/483/aurobindo-pharma-limited/32976071-2001-4f14-887c-76d96e0a30e8) — source: FDA, date: May 10, 2022
- [FDA Inspection 1169446 - Aurobindo Pharma Limited - 2022-05-10](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/b9201ac7-5ec4-46dd-8aaf-7304c3c93094) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2022
- [483 - Aurobindo Pharma Limited - 2019-09-27](https://www.keypedia.com/records/483/aurobindo-pharma-limited/7bfb2b5e-0991-4dcb-861b-ef0d934ade3d) — source: FDA, date: September 27, 2019
- [FDA Inspection 1105823 - Aurobindo Pharma Limited - 2019-09-27](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/65ccbba1-8a36-41aa-99c4-64321edccdd9) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1022788 - Aurobindo Pharma Limited - 2017-06-24](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/8d9ab63f-c6f2-4237-89f8-eb13c0866d60) — classification: No Action Indicated (NAI), source: FDA, date: June 24, 2017
- [FDA Inspection 927596 - Aurobindo Pharma Limited - 2015-03-13](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/6c7e4565-5d73-4395-b181-5abaff503b71) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2015
- [FDA Inspection 787128 - Aurobindo Pharma Limited - 2012-06-19](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/90d9c974-e3d8-49ad-961f-4caba97a4429) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 694644 - Aurobindo Pharma Limited - 2010-07-30](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/e2ec8cd8-27f8-4bb8-a70f-248992e68a88) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2010
- [FDA Inspection 636493 - Aurobindo Pharma Limited - 2009-10-13](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/68cd681c-fb9d-4d3c-99bd-d99b1eb05aba) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2009

## Related Companies

- [Fresenius Kabi USA LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/f694c817-29ea-47cf-b819-8cf11fbfc4da)
- [Apotex Inc.](https://www.keypedia.com/companies/apotex-inc/8126714d-6e9a-424d-9e8e-d10f38a8ab7b)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/286f1fa0-a9e6-4928-acc7-c3a4ef147b87)
- [Iso-Tex Diagnostics, Inc.](https://www.keypedia.com/companies/iso-tex-diagnostics-inc/59c59676-32cc-4749-b95d-3bdc31559b58)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/967df80c-3ba2-42c7-918c-af2c89dc721c)
- [JO Cosmetics Co., Ltd.](https://www.keypedia.com/companies/jo-cosmetics-co-ltd/024011ed-6193-499c-a620-451b3f6c41fe)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/d29a124f-fdcb-4108-9eac-661149b4d20e)
- [Fresenius Kabi USA, LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/6b662e1b-3996-48b4-a517-0d555d32a380)
- [APL HEALTHCARE LIMITED](https://www.keypedia.com/companies/apl-healthcare-limited/d13ff022-135e-4790-b958-7f0667d985ab)
- [Nang Kuang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nang-kuang-pharmaceutical-co-ltd/bdb8b0bb-4a8d-4f50-a72d-e250626e2818)

## Related Officers

- [Compliance Officer at FDA](https://www.keypedia.com/people/emmanuel-j-ramos/ba0666bd-2752-453e-9fd3-5e43b1cff3ad)
- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Consumer Safety Officer](https://www.keypedia.com/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)